AEMD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AEMD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Aethlon Medical's Ending Cash Position for the quarter that ended in Dec. 2023 was $8.06 Mil.
Aethlon Medical's quarterly Ending Cash Position declined from Jun. 2023 ($12.99 Mil) to Sep. 2023 ($10.26 Mil) and declined from Sep. 2023 ($10.26 Mil) to Dec. 2023 ($8.06 Mil).
Aethlon Medical's annual Ending Cash Position increased from Mar. 2021 ($9.91 Mil) to Mar. 2022 ($17.16 Mil) but then declined from Mar. 2022 ($17.16 Mil) to Mar. 2023 ($14.62 Mil).
The historical data trend for Aethlon Medical's Ending Cash Position can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aethlon Medical Annual Data | |||||||||||||||||||||
Trend | Mar14 | Mar15 | Mar16 | Mar17 | Mar18 | Mar19 | Mar20 | Mar21 | Mar22 | Mar23 | |||||||||||
Ending Cash Position | Get a 7-Day Free Trial | 3.83 | 9.61 | 9.91 | 17.16 | 14.62 |
Aethlon Medical Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Ending Cash Position | Get a 7-Day Free Trial | 17.59 | 14.62 | 12.99 | 10.26 | 8.06 |
Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.
Aethlon Medical's Ending Cash Position for the fiscal year that ended in Mar. 2023 is calculated as
Ending Cash Position | = | Beginning Cash Position | + | Net Change in Cash |
= | 17.153 | + | -2.533 | |
= | 14.62 |
Aethlon Medical's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as
Ending Cash Position | = | Beginning Cash Position | + | Net Change in Cash |
= | 10.264 | + | -2.204 | |
= | 8.06 |
Thank you for viewing the detailed overview of Aethlon Medical's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.
Nicolas Gikakis | director | 11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO CA 92121 |
Lee D Arnold | officer: Chief Scientific Officer | C/O ASSEMBLY BIOSCIENCES, INC., 99 HUDSON STREET, 5TH FLOOR, NEW YORK NY 10013 |
Angela Rossetti | director | PALATIN TECHNOLOGIES, INC., 4B CEDAR BROOK DRIVE, CRANBURY NJ 08512 |
Steven P Larosa | officer: Chief Medical Officer | 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA 92123 |
Chetan Shah | director | 9 GRACE HILL COURT, TITUSVILLE NJ 08560 |
Fisher Charles J Jr | director | C/O AETHLON MEDICAL, INC., 9635 GRANITE RIDGE DR., SUITE 100, SAN DIEGO CA 92123 |
Guy F. Cipriani | director | 1727 EAGLERIDGE DRIVE, BELLINGHAM WA 98226 |
Sabrina Martucci Johnson | director | 11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037 |
Rodell Timothy C Jr | officer: Interim CEO | 201 MIDLAND AVE, ASPEN CO 81611 |
Weiner Family Revocable Trust Ellen R. | 10 percent owner | 10645 N. TATUM BOULEVARD, SUITE 200-166, PHOENIX AZ 85028 |
Phillip A Ward | director | 8910 UNIVERSITY CENTER LANE #660, SAN DIEGO CA 92122 |
Thomas V Wornham | director | 8910 UNIVERSITY CENTER LANE #660, SAN DIEGO CA 92122 |
Rodney S Kenley | director, officer: President | 9635 GRANITE RIDGE DRIVE, SUITE 100, SAN DIEGO CA 92123 |
James B Frakes | officer: Chief Financial Officer | 9635 GRANITE RIDGE DRIVE, SUITE 100, SAN DIEGO CA 92123 |
Barry Franklyn S Jr | director | 1141 DELAWARE AVENUE #3N, BUFFALO NY 14209 |
From GuruFocus
By PRNewswire • 10-04-2023
By PRNewswire PRNewswire • 07-08-2022
By PRNewswire PRNewswire • 01-30-2023
By PRNewswire • 07-24-2023
By PRNewswire • 06-22-2023
By PRNewswire PRNewswire • 01-31-2023
By PRNewswire PRNewswire • 07-25-2022
By PRNewswire PRNewswire • 08-01-2022
By PRNewswire PRNewswire • 05-22-2023
By PRNewswire PRNewswire • 07-28-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.